CAN EFFICIENCY OF FOLLOW-UP FOR SUPERFICIAL BLADDER-CANCER BE INCREASED

被引:0
|
作者
GULLIFORD, MC
PETRUCKEVITCH, A
BURNEY, PGJ
机构
基金
英国惠康基金;
关键词
BLADDER NEOPLASMS; CYSTOSCOPY; EFFICIENCY; OPERATIONS RESEARCH;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study evaluated the efficiency with which follow-up cystoscopy was employed in a population-based cohort of patients with superficial bladder cancer. Subjects were 240 men, aged under 75 years, with superficial bladder cancer first diagnosed in 1982. The median duration of follow-up was 6.1 years. The median (interquartile range) number of follow-up cystoscopies was 8 (5-12) per patient with a patient-specific annual rate of 1.7 (1.2-2.2) per year. The median number of cystoscopies at which recurrent tumour was detected was 2 (0-5) per patient, patient-specific annual rate 0.4 (0.0-1.3) per year of follow-up. Among patients with a single tumour at diagnosis and a negative first check cystoscopy (MRC group 1), the proportion of positive cystoscopies was 0.1 (0.0-0.4). Comparison of observed intervals between cystoscopies with optimal intervals calculated using an optimisation model showed that patients in MRC group 1 were seen sooner in practice than the model predicted, while in practice other patients were seen later than the model predicted. These data support the suggestion that efficiency of follow-up for patients with superficial bladder cancer could be increased by dividing patients into groups with different risks of recurrence and differing follow-up requirements.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [1] Follow-up in superficial and metastatic bladder cancer
    Zraik, Isabella
    Krege, Susanne
    UROLOGE, 2022, 61 (05): : 477 - 483
  • [2] BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER - A 10-YEAR FOLLOW-UP
    HERR, HW
    WARTINGER, DD
    FAIR, WR
    OETTGEN, HF
    JOURNAL OF UROLOGY, 1992, 147 (04) : 1020 - 1023
  • [3] BLADDER-CANCER AND THE RISK OF SMOKING-RELATED CANCERS DURING FOLLOW-UP
    SALMINEN, E
    PUKKALA, E
    TEPPO, L
    JOURNAL OF UROLOGY, 1994, 152 (05) : 1420 - 1423
  • [4] NEOADJUVANT CISPLATIN, METHOTREXATE AND VINBLASTINE FOR MUSCLE-INVASIVE BLADDER-CANCER - LONG-TERM FOLLOW-UP
    DREICER, R
    KOLLMORGEN, TA
    SMITH, RF
    WILLIAMS, RD
    JOURNAL OF UROLOGY, 1993, 150 (03) : 849 - 852
  • [5] PHARMACOKINETICS OF INTRAVESICAL DOXORUBICIN IN SUPERFICIAL BLADDER-CANCER PATIENTS
    CHAI, M
    WIENTJES, MG
    BADALAMENT, RA
    BURGERS, JK
    AU, JLS
    JOURNAL OF UROLOGY, 1994, 152 (02) : 374 - 378
  • [6] INTEGRAL PHOTODYNAMIC TREATMENT OF REFRACTORY SUPERFICIAL BLADDER-CANCER
    KRIEGMAIR, M
    WAIDELICH, R
    LUMPER, W
    EHSAN, A
    BAUMGARTNER, R
    HOFSTETTER, A
    JOURNAL OF UROLOGY, 1995, 154 (04) : 1339 - 1341
  • [7] PRIMARY METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN CHEMOTHERAPY AND BLADDER PRESERVATION IN LOCALLY INVASIVE BLADDER-CANCER - A 5-YEAR FOLLOW-UP
    SROUGI, M
    SIMON, SD
    JOURNAL OF UROLOGY, 1994, 151 (03) : 593 - 597
  • [8] P53 GENE MUTATION IN RECURRENT SUPERFICIAL BLADDER-CANCER
    YOSHIMURA, I
    KUDOH, J
    SAITO, S
    TAZAKI, H
    SHIMIZU, N
    JOURNAL OF UROLOGY, 1995, 153 (05) : 1711 - 1715
  • [9] PHASE-1 TRIAL OF ORAL BROPIRIMINE IN SUPERFICIAL BLADDER-CANCER
    SAROSDY, MF
    LAMM, DL
    WILLIAMS, RD
    MOON, TD
    FLANIGAN, RC
    CRAWFORD, ED
    WILKS, NE
    EARHART, RH
    MERRITT, JA
    JOURNAL OF UROLOGY, 1992, 147 (01) : 31 - 33
  • [10] GRADING OF SUPERFICIAL BLADDER-CANCER BY QUANTITATIVE MITOTIC FREQUENCY-ANALYSIS
    LIPPONEN, PK
    ESKELINEN, MJ
    JAUHIAINEN, K
    HARJU, E
    TERHO, R
    HAAPASALO, H
    JOURNAL OF UROLOGY, 1993, 149 (01) : 36 - 41